AKT1 and neoplasm: This inactivation was correlated with the tumour-suppressive function of SLC41A1, as evidenced by the observation that recovery of Akt activity with SC79 (10 μg/mL) markedly abrogated the inhibition of PDAC cell proliferation by SLC41A1 overexpression (Figure 5B).